How this company measures up on the fundamentals that matter
Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising practice management software, AI patient scheduling software, and electronic statements and payments, and payerpath clearinghouse; revenue cycle services and coding services; electronic health records solutions, which include eprescribe with EPCS, EHR software, veradigm EHR, and practice fusion EHR; and patient engagement platform. It also provides solutions to network partners, which comprise API connectivity solutions, such as veradigm connect, veradigm app expo, and diagnostic ordering and resulting network; life sciences, health plans and payers, and providers; and veradigm eprescribe enterprise. In addition, the company offers risk adjustment solutions, such as health equity analytics, risk adjustment analytics, risk mitigator, comprehensive submissions, and utilization analytics; quality analytics, risk adjustment, and quality management; data exchange and coding solutions, including echart courier, echart coder, and echart integration and analytics; clinical data registries for physicians and veradigm payer insights; provider engagement solutions; care gap alerting, gap closure services, and veradigm payerpath solutions. Further, it provides real world data solutions, such as NLP-enriched EHR data solutions, and clinical data registries; real world evidence and real-world evidence analytics platform; and digital health media solutions. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.
Five compliance checks based on AAOIFI standards — all must pass for ethical clearance
Trading at $5, 9% above fair value of $4. Fails ethical screen (Debt ratio). Ranks better than 6% of screened stocks.
Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data
Trading characteristics and market positioning
Balance sheet strength and cash generation — the foundation of long-term value
SEC Form 4 filings — what company insiders are buying and selling
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-01 | JACOBSON ERIC L | General Counsel | 75,000 | — | |
| 2026-04-01 | SYED TEHSIN M | Officer | 220,986 | — | |
| 2026-04-01 | BAKER TALLY | Officer | 110,493 | — | |
| 2026-04-01 | TRIGG DONALD | Chief Executive Officer | 552,465 | — | |
| 2025-11-03 | SYED TEHSIN M | Chief Technology Officer | 423,998 | — | |
| 2025-11-03 | BAKER TALLY | Officer | 105,999 | — | |
| 2025-09-02 | TRIGG DONALD | Chief Executive Officer | 571,428 | $2,999,997 | |
| 2025-06-02 | FELT BRUCE C. JR. | Director | 46,512 | $200,002 | |
| 2025-06-02 | ASAR VINIT K. | Director | 46,512 | $200,002 | |
| 2025-06-02 | STEVENS DAVID B | Director | 46,512 | $200,002 |
Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-14